OPGN
Opgen Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.
Market Cap: 5.34 Million
Primary Exchange: NASDAQ
Website: http://opgen.com/
Shares Outstanding: 10 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.3223243696583489
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Ethical Flags
Longest drawdown: 684 trading days
From: 2015-05-05 To: 2018-01-23
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2018-01-19 | 25.0 | 1.0 | 25.0 |